India has set up 179 centres to monitor adverse drug reactions across the country
The Indian Pharmacopoeia Commission (IPC) is set to become the first World Health Organisation (WHO) Collaborating Centre for the safety of medicines and vaccines in the south and south-east Asia region. These bodies work with the WHO to develop and implement policy.
The move has been welcomed by Indian health and Welfare Minister Shri J P Nadda, who stressed the need to improve pharmacovigilance in the region as 'an effective instrument for understanding and prevention of adverse effects or any other drug related problems'.
He noted that India has set up 179 centres to monitor adverse drug reactions across the country.
